CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Biocryst Pharmaceuticals Inc  (BCRX)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Biocryst Pharmaceuticals Inc's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

BCRX Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Revenue Change 95.79 % 95.2 % -29.34 % -81.48 % -29.39 %
Y / Y Gross Profit Change - 45.51 % - - -
Gross Margin - 74.43 % - - -
Gross Margin Total Ranking # 524 # 1504 # 612 # 668 # 663
Seq. Revenue Change 5.05 % 15.72 % 62.17 % -0.68 % 4.74 %
Seq. Gross Profit Change - -13.87 % - - -


Commenting First Quarter 2017 Gross Margin
Biocryst Pharmaceuticals Inc Gross Profit grew by 41.15 % in I. Quarter sequntially to 9 millions, while Revenue increased by 5.05 %, this led to improvement in Company's Gross Margin to 100 % a new company high.

Observing first quarter 2017 results within Biotechnology & Drugs industry 45 other companies have achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 524, from total ranking in previous quarter at 1504.
Learn about Gross Margin
BCRX's Gross Margin first quarter 2017 Company Ranking
Within: No.
Industry # 46
Sector # 145
S&P 500 # 524

Gross Margin Statistics
High Average Low
100 % 98.18 % 74.43 %
(Mar 31 2017)   (Dec 31 2016)

You need to upgrade your Flash Player


Financial Statements
Biocryst Pharmaceuticals Inc's (Mar 31 2017) Gross Profit $ 9 BCRX's Income Statement
Biocryst Pharmaceuticals Inc's (Mar 31 2016) Gross Profit $ 5 Quarterly BCRX's Growth
BCRX's Profits by Division See BCRX's Profits by Segment

Other Gross Margin Profitability Ratios
BCRX's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
BCRX's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for BCRX's Competitors
Gross Margin Profit Margin for Biocryst Pharmaceuticals Inc's Suppliers
Gross Margin Profit Margin for BCRX's Customers

You may also want to know
BCRX's Annual Growth Rates BCRX's Profitability Ratios BCRX's Asset Turnover Ratio BCRX's Dividend Growth
BCRX's Roe BCRX's Valuation Ratios BCRX's Financial Strength Ratios BCRX's Gross Profit Growth
BCRX's Roa BCRX's Inventory Turnover Ratio BCRX's Growth Rates BCRX's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Biotechnology & Drugs Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Sangui Biotech International Inc  217.68 %$ 0.025 $ 0.012 
Juno Therapeutics, Inc.  100.00 %$ 19.327 $ 19.327 
Idera Pharmaceuticals, Inc.  100.00 %$ 0.378 $ 0.378 
Innovus Pharmaceuticals, Inc.  100.00 %$ 2.177 $ 2.177 
Kite Pharma, Inc.  100.00 %$ 9.836 $ 9.836 
Mymetics Corp  100.00 %$ 0.383 $ 0.383 
Momenta Pharmaceuticals Inc  100.00 %$ 26.614 $ 26.614 
Fate Therapeutics Inc  100.00 %$ 1.027 $ 1.027 
Dimension Therapeutics, Inc.  100.00 %$ 3.618 $ 3.618 
Curis Inc  100.00 %$ 2.131 $ 2.131 
Cocrystal Pharma, Inc.  100.00 %$ 0.002 $ 0.002 
Crispr Therapeutics Ag  100.00 %$ 2.703 $ 2.703 
Cytomx Therapeutics, Inc.  100.00 %$ 11.653 $ 11.653 
Myokardia Inc  100.00 %$ 5.625 $ 5.625 
Neuralstem, Inc.  100.00 %$ 0.003 $ 0.003 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.029 $ 0.029 
Nantkwest, Inc.  100.00 %$ 0.011 $ 0.011 
Regenerx Biopharmaceuticals Inc  100.00 %$ 0.013 $ 0.013 
Proteostasis Therapeutics, Inc.  100.00 %$ 1.021 $ 1.021 
Repros Therapeutics Inc.  100.00 %$ 0.007 $ 0.007 
Sangamo Therapeutics, Inc  100.00 %$ 3.425 $ 3.425 
Tracon Pharmaceuticals, Inc.  100.00 %$ 0.626 $ 0.626 
Syndax Pharmaceuticals Inc  100.00 %$ 0.305 $ 0.305 
Proteo Inc  100.00 %$ 0.038 $ 0.038 
Tg Therapeutics, Inc.  100.00 %$ 0.038 $ 0.038 
Intellia Therapeutics, Inc.  100.00 %$ 6.215 $ 6.215 
Cannabics Pharmaceuticals Inc.  100.00 %$ 0.001 $ 0.001 
Novavax Inc  100.00 %$ 5.680 $ 5.680 
Spark Therapeutics, Inc.  100.00 %$ 1.274 $ 1.274 
Pulse Biosciences, Inc.  100.00 %$ 0.039 $ 0.039 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
KWBT's Profile
Stock Price
KWBT's Financials
KWBT's Expectations
Business Description
Fundamentals
Charts & Quotes
KWBT's News
Suppliers
KWBT's Competitors
Customers & Markets
Economic Indicators
KWBT's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com